Table 3 Participants with CKD Stages 3–5 at Baseline
CKD Stage (eGFR mL/min/1.73 m2) | n (%) |
|---|---|
Overall CKD Prevalence, Stages 3–5 combined (< 60) | 42 (7.4) |
Stage 3a (45 to < 60) | 9 (1.6) |
Stage 3b (30 to < 45) | 16 (2.8) |
Stage 4 (15 to < 30) | 9 (1.6) |
Stage 5 (< 15) | 7 (1.2) |